金域医学: 广州金域医学检验集团股份有限公司关于计提资产减值准备的公告

Summary of Key Points Core Viewpoint - The company has announced the provision for asset impairment to objectively and fairly reflect its financial status and operating results for the first half of 2025, in accordance with relevant accounting standards and policies [1][2]. Group 1: Asset Impairment Provision Overview - The company has recognized a total asset impairment provision of 272,349,303.43 RMB for the period from January to June 2025, which includes credit impairment losses of 272,474,717.40 RMB and asset impairment losses of -125,413.97 RMB [1]. - The credit impairment losses consist of 271,491,843.98 RMB from accounts receivable and 982,873.42 RMB from other receivables [1]. - The company employs an aging analysis method to assess expected credit losses based on credit risk characteristics [1]. Group 2: Specifics of Credit Impairment Losses - The company categorizes receivables into different groups based on credit risk characteristics, with Group One consisting of related party receivables and guarantees not subject to impairment provisions [1]. - Group Two includes other receivables, where the company applies an aging analysis method to calculate expected credit losses [1]. Group 3: Impact of Asset Impairment Provision - The provision for asset impairment is based on the principle of prudence and aligns with accounting standards, reflecting the company's actual situation and providing investors with more reliable and accurate financial information [2][3].